Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response

Journal of Infectious Diseases

Volumn 197, Issue 11, 2008, Pages 1594-1597

  Bell, Melissa J ^a   Brennan, Rebekah ^a   Miles, John J ^a   Moss, Denis J ^a   Burrows, Jacqueline M ^a   Burrows, Scott R ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; HLA B8 ANTIGEN; TYROSYLASPARAGINYLLEUCYLARGINYLARGINYLGLYCYLISOLEUCYLALANYLLEUCINE; TYROSYLASPARAGINYLLEUCYLARGINYLARGINYLGLYCYLTHREONYLALANYLLEUCINE;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ANTIGEN FUNCTION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; EPISOME; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; T LYMPHOCYTE; VIRUS STRAIN; WILD TYPE;

EPITOPES, T-LYMPHOCYTE; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES;

EID: 43949145245     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/587848     Document Type: Article

References (15)

1. Sample J, Young L, Martin B, et al. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 1990; 64:4084-92.
2. Yates J, Warren N, Reisman D, Sugden B. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 1984; 81:3806-10.
3. Lee SP, Brooks JM, Al-Jarrah H, et al. CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1. J Exp Med 2004; 199:1409-20.
4. Tellam J, Connolly G, Green KJ, et al. Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1. J Exp Med 2004; 199:1421-31.
5. + T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J Exp Med 2000; 191:1649-60.
6. Baer R, Bankier AT, Biggin MD, et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984; 310:207-11.
7. Habeshaw G, Yao QY, Bell AI, Morton D, Rickinson AB. Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. J Virol 1999; 73:965-75.
8. Bhatia K, Raj A, Guitierrez MI, et al. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 1996; 13:177-81.
9. Wrightham MN, Stewart JP, Janjua NJ, et al. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 1995; 208:521-30.
10. Snudden DK, Smith PR, Lai D, Ng MH, Griffin BE. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Oncogene 1995; 10:1545-52.
11. Pope JH. Establishment of cell lines from Australian leukaemic patients: presence of a herpes-like virus. Aust J Exp Biol Med Sci 1968; 46:643-5.
12. Apolloni A, Sculley TB. Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology 1994; 202:978-81.
13. Voo KS, Fu T, Wang HY, et al. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes. J Exp Med 2004; 199:459-70.
14. Altmann M, Pich D, Ruiss R, Wang J, Sugden B, Hammerschmidt W. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc Natl Acad Sci USA 2006; 103:14188-93.
15. Ambinder RF, Mullen MA, Chang YN, Hayward GS, Hayward SD. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J Virol 1991; 65:1466-78.